vetmedin vet. (pimovita) tuggutafla 1,25 mg
boehringer ingelheim vetmedica gmbh* - pimobendanum inn - tuggutafla - 1,25 mg
vetmedin vet. (pimovita) tuggutafla 10 mg
boehringer ingelheim vetmedica gmbh* - pimobendanum inn - tuggutafla - 10 mg
vetmedin vet. (pimovita) tuggutafla 5 mg
boehringer ingelheim vetmedica gmbh* - pimobendanum inn - tuggutafla - 5 mg
cresemba
basilea pharmaceutica deutschland gmbh - isavuconazol - aspergillosis - cresemba er ætlað í fullorðnir fyrir meðferð:innrásar aspergillosismucormycosis í sjúklingar sem amfótericín b er inappropriateconsideration ætti að opinbera leiðsögn á réttri notkun mikla lyfjum.
euthasol vet. stungulyf, lausn 400 mg/ml
le vet b.v.* - pentobarbitalum natríum - stungulyf, lausn - 400 mg/ml
ficoxil tuggutafla 227 mg
livisto int'l, s.l. - firocoxibum inn - tuggutafla - 227 mg
ficoxil tuggutafla 57 mg
livisto int'l, s.l. - firocoxibum inn - tuggutafla - 57 mg
abiraterone mylan
mylan ireland limited - abirateron asetat - blöðruhálskirtli - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
levetiracetam stada mixtúra, lausn 100 mg/ml
stada arzneimittel ag - levetiracetamum inn - mixtúra, lausn - 100 mg/ml
busol stungulyf, lausn 0,004 mg/ml
t.p. whelehan son & co. ltd. - buserelinum acetat - stungulyf, lausn - 0,004 mg/ml